Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery
Status:
Unknown status
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
Primary objective of the study is to compare requirement of blood transfusion and mortality
in patients receiving Tranexamic acid (Cyklokapron®) and those not receiving it.
Secondary objective is to; assess the re-bleeding events; need for surgical intervention;
length of stay in Intensive care unit in between the two groups.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Tribhuvan University Teaching Hospital, Institute Of Medicine.